FDA — authorised 15 August 2014
- Application: BLA125499
- Marketing authorisation holder: BIOGEN IDEC INC
- Local brand name: PLEGRIDY
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 SC Peginterferon beta-1a in United States
FDA authorised SC Peginterferon beta-1a on 15 August 2014
Marketing authorisation
SC Peginterferon beta-1a in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is SC Peginterferon beta-1a approved in United States?
Yes. FDA authorised it on 15 August 2014.
Who is the marketing authorisation holder for SC Peginterferon beta-1a in United States?
BIOGEN IDEC INC holds the US marketing authorisation.